THE TGA has updated its website
with two new AusPARs for Axanum
(aspirin/esomeprazole) and Zaldiar
paracetamol).The above snippet is the first part of an article sent to subscribers in Pharmacy Daily's issue from 03 Oct 12 To see the full story, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 03 Oct 12
CONSUMERS and health professionals are advised that Biogen Australia, in consultation with the Therapeutic Goods Administration (TGA), will withdraw multiple sclerosis therapy Zinbryta (daclizumab) from the Australian market following a review of cases of serious inflammatory brain disorders in Europe (PD 05 Mar).